Pharma-export Ltd

POWER SEARCH PRICING

SOLUTIONS

pharma-export ltd Company Information

Live

MatureSmallDeclining

Company Number

04746248

Website

http://pharma-export.com

Registered Address

office f9, silverbox house, 56 magnet road, wembley, middx., HA9 7FP

Industry

Wholesale of pharmaceutical goods

Telephone

02039037473

Next Accounts Due

January 2025

Group Structure

View All

Directors

Benno Sabapathy16 Years

Shareholders

deven madhvani 50%

miss sonia amrit 25%

View All

pharma-export ltd Estimated Valuation

£978.1k

Pomanda estimates the enterprise value of PHARMA-EXPORT LTD at £978.1k based on a Turnover of £1.6m and 0.62x industry multiple (adjusted for size and gross margin).

Edit your figures and get a professional valuation report.

Pharma-export Ltd AI Business Plan

In just minutes, we combine Pomanda’s company and industry data with cutting edge Artificial Intelligence to build a comprehensive 27 section business plan. You then have 60 days to tailor the information, decide which sections to include or exclude, and add your own branding logos, images and color scheme to create your perfect plan.

View Sample

Pharma-export Ltd is a live company located in wembley, HA9 7FP with a Companies House number of 04746248. It operates in the wholesale of pharmaceutical goods sector, SIC Code 46460. Founded in April 2003, it's largest shareholder is deven madhvani with a 50% stake. Pharma-export Ltd is a mature, small sized company, Pomanda has estimated its turnover at £1.6m with declining growth in recent years.

View Sample

Upgrade for unlimited company reports & a free credit check

Pomanda's financial health check has awarded Pharma-Export Ltd a 2 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 7 areas for improvement. Company Health Check FAQs

Health Rating2out of 5

2 Strong

3 Regular

7 Weak

Size

annual sales of £1.6m, make it smaller than the average company (£24.7m)

Growth

3 year (CAGR) sales growth of -7%, show it is growing at a slower rate (4.7%)

Very Low Risk70 - 100

Low Risk50 - 70

Moderate Risk30 - 50

High Risk20 - 30

Very High Risk0 - 20

Get a comprehensive credit check for pharma-export ltd. Get real-time insights into pharma-export ltd's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Perform a competitor analysis for pharma-export ltd by selecting its closest rivals and benchmarking them against 12 key performance metrics.

PHARMA-EXPORT LTD group structure

Pharma-Export Ltd has no subsidiary companies.

Ultimate parent company

PHARMA-EXPORT LTD

04746248

PHARMA-EXPORT LTD Shareholders

deven madhvani	50%
miss sonia amrit	25%
benno ranjitkumar sabapathy	25%

Pharma-Export Ltd currently has 1 director, Mr Benno Sabapathy serving since Apr 2008.

officer	country	age	start	end	role
Mr Benno Sabapathy	England	56 years	Apr 2008	-	Director

EXPORT

Pharma-Export Ltd's latest turnover from April 2023 is estimated at £1.6 million and the company has net assets of £80.2 thousand. According to their latest financial statements, Pharma-Export Ltd has 5 employees and maintains cash reserves of £12.1 thousand as reported in the balance sheet.

Data source: Companies House, Pomanda Estimates

	Apr 2023	Apr 2022	Apr 2021	Apr 2020	Apr 2019	Apr 2018	Apr 2017	Apr 2016	Apr 2015	Apr 2014	Apr 2013	Apr 2012	Apr 2011	Apr 2010
Turnover	1,588,305	3,351,875	1,849,046	1,958,739	4,684,464	4,828,986	5,886,422	4,025,965	3,249,810	3,673,733	3,497,482	1,004,196	1,605,611	2,618,934
Other Income Or Grants	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cost Of Sales	1,194,644	2,553,821	1,423,772	1,487,656	3,601,874	3,724,730	4,443,477	2,994,520	2,381,701	2,748,175	2,659,176	804,559	1,575,769	2,012,775
Gross Profit	393,662	798,053	425,274	471,083	1,082,591	1,104,256	1,442,946	1,031,445	868,108	925,558	838,306	199,637	29,842	606,159
Admin Expenses	341,146	762,988	398,225	624,767	1,019,463	1,054,247	1,231,654	1,026,173	932,353	910,529	878,526	71,950	111,834	476,125
Operating Profit	52,516	35,065	27,049	-153,684	63,128	50,009	211,292	5,272	-64,245	15,029	-40,220	127,687	-81,992	130,034
Interest Payable	10,686	7,104	2,681	0	0	0	0	0	0	0	0	56,652	155,761	0
Interest Receivable	2,330	1,259	148	29	0	0	21	85	185	218	200	0	0	496
Pre-Tax Profit	44,160	29,220	24,516	-153,655	63,128	50,009	211,314	5,358	-64,060	15,247	-40,020	71,035	-236,235	130,530
Tax	-11,040	-5,552	-4,658	0	-11,994	-9,502	-40,150	-1,071	0	-3,202	0	0	0	-27,411
Profit After Tax	33,120	23,668	19,858	-153,655	51,134	40,507	171,164	4,286	-64,060	12,045	-40,020	71,035	-236,235	103,119
Dividends Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	60,000
Retained Profit	33,120	23,668	19,858	-153,655	51,134	40,507	171,164	4,286	-64,060	12,045	-40,020	71,035	-236,235	43,119
Employee Costs	343,165	381,462	299,317	282,400	269,581	516,736	597,185	359,385	256,305	329,750	282,713	37,496	38,372	233,655
Number Of Employees	5	6	5	5	5	9	12	8	6	8	7	2	4	6
EBITDA*	54,528	37,236	28,722	-151,593	63,128	50,009	211,292	5,577	-63,838	15,350	-39,792	127,687	-81,992	130,034

* Earnings Before Interest, Tax, Depreciation and Amortisation

	Apr 2023	Apr 2022	Apr 2021	Apr 2020	Apr 2019	Apr 2018	Apr 2017	Apr 2016	Apr 2015	Apr 2014	Apr 2013	Apr 2012	Apr 2011	Apr 2010
Tangible Assets	6,035	6,517	5,022	6,274	2,607	2,042	1,674	917	1,222	964	1,285	0	0	0
Intangible Assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Investments & Other	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Debtors (Due After 1 year)	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Fixed Assets	6,035	6,517	5,022	6,274	2,607	2,042	1,674	917	1,222	964	1,285	0	0	0
Stock & work in progress	274,699	76,784	118,611	98,435	0	0	0	13,275	5,279	72,563	17,106	0	0	0
Trade Debtors	76,904	578,584	97,123	268,655	811,068	679,897	873,777	688,039	507,101	572,133	583,001	273,569	39,153	1,237,180
Group Debtors	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Misc Debtors	343,698	401,864	502,119	0	0	0	0	0	0	0	0	378,850	358,662	0
Cash	12,128	97,521	238,129	57,076	0	0	0	16,997	17,067	57,079	30,039	50,133	120,924	210,571
misc current assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0
total current assets	707,429	1,154,753	955,982	424,166	811,068	679,897	873,777	718,311	529,447	701,775	630,146	702,552	518,739	1,447,751
total assets	713,464	1,161,270	961,004	430,440	813,675	681,939	875,451	719,228	530,669	702,739	631,431	702,552	518,739	1,447,751
Bank overdraft	24,278	43,114	52,568	0	0	0	0	0	0	0	0	0	0	0
Bank loan	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Trade Creditors	260,193	639,920	424,756	387,592	671,644	635,883	869,902	884,842	700,569	808,579	749,316	450,957	277,970	1,360,416
Group/Directors Accounts	0	0	0	0	0	0	0	0	0	0	0	0	0	0
other short term finances	0	0	0	0	0	0	0	0	0	0	0	0	0	0
hp & lease commitments	0	0	0	0	0	0	0	0	0	0	0	0	0	0
other current liabilities	287,180	351,689	424,967	0	0	0	0	0	0	0	0	329,460	389,669	0
total current liabilities	571,651	1,034,723	902,291	387,592	671,644	635,883	869,902	884,842	700,569	808,579	749,316	780,417	667,639	1,360,416
loans	61,632	79,486	35,320	0	0	0	0	0	0	0	0	0	0	0
hp & lease commitments	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Accruals and Deferred Income	0	0	0	0	0	0	0	0	0	0	0	0	0	0
other liabilities	0	0	0	39,313	44,841	0	0	0	0	0	0	0	0	0
provisions	0	0	0	0	0	0	0	0	0	0	0	0	0	0
total long term liabilities	61,632	79,486	35,320	39,313	44,841	0	0	0	0	0	0	0	0	0
total liabilities	633,283	1,114,209	937,611	426,905	716,485	635,883	869,902	884,842	700,569	808,579	749,316	780,417	667,639	1,360,416
net assets	80,181	47,061	23,393	3,535	97,190	46,056	5,549	-165,614	-169,900	-105,840	-117,885	-77,865	-148,900	87,335
total shareholders funds	80,181	47,061	23,393	3,535	97,190	46,056	5,549	-165,614	-169,900	-105,840	-117,885	-77,865	-148,900	87,335

	Apr 2023	Apr 2022	Apr 2021	Apr 2020	Apr 2019	Apr 2018	Apr 2017	Apr 2016	Apr 2015	Apr 2014	Apr 2013	Apr 2012	Apr 2011	Apr 2010
Operating Activities
Operating Profit	52,516	35,065	27,049	-153,684	63,128	50,009	211,292	5,272	-64,245	15,029	-40,220	127,687	-81,992	130,034
Depreciation	2,012	2,171	1,673	2,091	0	0	0	305	407	321	428	0	0	0
Amortisation	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Tax	-11,040	-5,552	-4,658	0	-11,994	-9,502	-40,150	-1,071	0	-3,202	0	0	0	-27,411
Stock	197,915	-41,827	20,176	98,435	0	0	-13,275	7,996	-67,284	55,457	17,106	0	0	0
Debtors	-559,846	381,206	330,587	-542,413	131,171	-193,880	185,738	180,938	-65,032	-10,868	-69,418	254,604	-839,365	1,237,180
Creditors	-379,727	215,164	37,164	-284,052	35,761	-234,019	-14,940	184,273	-108,010	59,263	298,359	172,987	-1,082,446	1,360,416
Accruals and Deferred Income	-64,509	-73,278	424,967	0	0	0	0	0	0	0	-329,460	-60,209	389,669	0
Deferred Taxes & Provisions	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cash flow from operations	-38,817	-165,809	135,432	8,333	-44,276	368	-16,261	-155	-39,532	26,822	-18,581	-14,139	64,596	225,859
Investing Activities
capital expenditure	-1,530	-3,666	-421	-5,758	-565	-368	-757	0	-665	0	-1,713	0	0	0
Change in Investments	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash flow from investments	-1,530	-3,666	-421	-5,758	-565	-368	-757	0	-665	0	-1,713	0	0	0
Financing Activities
Bank loans	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Group/Directors Accounts	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Short Term Loans	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Long term loans	-17,854	44,166	35,320	0	0	0	0	0	0	0	0	0	0	0
Hire Purchase and Lease Commitments	0	0	0	0	0	0	0	0	0	0	0	0	0	0
other long term liabilities	0	0	-39,313	-5,528	44,841	0	0	0	0	0	0	0	0	0
share issue	0	0	0	60,000	0	0	-1	0	0	0	0	0	0	44,216
interest	-8,356	-5,845	-2,533	29	0	0	21	85	185	218	200	-56,652	-155,761	496
cash flow from financing	-26,210	38,321	-6,526	54,501	44,841	0	20	85	185	218	200	-56,652	-155,761	44,712
cash and cash equivalents
cash	-85,393	-140,608	181,053	57,076	0	0	-16,997	-70	-40,012	27,040	-20,094	-70,791	-89,647	210,571
overdraft	-18,836	-9,454	52,568	0	0	0	0	0	0	0	0	0	0	0
change in cash	-66,557	-131,154	128,485	57,076	0	0	-16,997	-70	-40,012	27,040	-20,094	-70,791	-89,647	210,571

P&L

April 2023

turnover

1.6m

-53%

operating profit

52.5k

gross margin

24.8%

+4.1%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

April 2023

net assets

80.2k

+0.7%

total assets

713.5k

-0.39%

cash

12.1k

-0.88%

net assets

Total assets minus all liabilities

Similar Companies

Agree?

steritech limited

3.5

rafarm uk limited

recordati rare diseases uk limited

fairview health limited

ananta medicare ltd

3.5

company number

04746248

Type

Private limited with Share Capital

industry

46460 - Wholesale of pharmaceutical goods

incorporation date

April 2003

age

accounts

Total Exemption Full

ultimate parent company

None

previous names

N/A

incorporated

address

office f9, silverbox house, 56 magnet road, wembley, middx., HA9 7FP

last accounts submitted

April 2023

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We did not find charges/mortgages relating to pharma-export ltd.

pharma-export ltd Company Information

pharma-export ltd Estimated Valuation

pharma-export ltd Estimated Valuation

pharma-export ltd Estimated Valuation

Pharma-export Ltd AI Business Plan

Pharma-export Ltd Overview

Pharma-export Ltd Health Check

pharma-export ltd Credit Report and Business Information

Pharma-export Ltd Competitor Analysis

pharma-export ltd Ownership

pharma-export ltd directors

PHARMA-EXPORT LTD financials

pharma-export ltd company details

pharma-export ltd Charges & Mortgages

pharma-export ltd Companies House Filings - See Documents